Bank Of America Corp Alector, Inc. Transaction History

Bank Of America Corp

$1.06 Trillion
Q1 2024

A detailed history of Bank Of America Corp transactions in Alector, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 353,651 shares of ALEC stock, worth $1.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

353,651

Previous 440,315 19.68%

Holding current value

$1.53 Million

Previous $3.51 Million 39.42%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$5.69 - $8.08 $493,118 - $700,245	-86,664 Reduced 19.68%	353,651 $2.13 Million
Q4 2023 Feb 14, 2024	BUY	$3.77 - $8.39 $321,015 - $714,408	85,150 Added 23.97%	440,315 $3.51 Million
Q2 2023 Aug 14, 2023	SELL	$5.86 - $7.93 $683,791 - $925,335	-116,688 Reduced 24.73%	355,165 $2.13 Million
Q1 2023 May 12, 2023	BUY	$5.85 - $9.84 $278,068 - $467,724	47,533 Added 11.2%	471,853 $2.92 Million
Q4 2022 Feb 10, 2023	BUY	$6.88 - $9.55 $385,142 - $534,609	55,980 Added 15.2%	424,320 $3.92 Million

Q3 2022 Nov 14, 2022	BUY	$8.19 - $13.2 $1.13 Million - $1.83 Million	138,363 Added 60.16%	368,340 $3.48 Million
Q2 2022 Aug 12, 2022	SELL	$7.65 - $14.24 $785,463 - $1.46 Million	-102,675 Reduced 30.87%	229,977 $2.34 Million
Q1 2022 May 16, 2022	SELL	$13.02 - $20.78 $1.02 Million - $1.63 Million	-78,356 Reduced 19.06%	332,652 $4.74 Million
Q4 2021 Feb 08, 2022	BUY	$19.35 - $25.54 $2.75 Million - $3.62 Million	141,861 Added 52.71%	411,008 $8.49 Million
Q3 2021 Nov 15, 2021	BUY	$21.65 - $39.49 $3.06 Million - $5.58 Million	141,372 Added 110.64%	269,147 $6.14 Million
Q2 2021 Sep 13, 2021	BUY	$15.5 - $22.48 $1.98 Million - $2.87 Million	127,775 New	127,775 $2.66 Million

Others Institutions Holding ALEC

# of Institutions

161

Shares Held

59.8M

Call Options Held

67.8K

Put Options Held

200

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $358M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Alector, Inc. Transaction History